But because Retatrutide is still experimental, real-world results and long-term safety are unknown
Tirzepatide at the highest dose produced even more dramatic results, with average weight loss reaching 20.2% in the SURMOUNT-5 trial
Long before significant weight loss has occurred
The practical result is that you feel full sooner and stay full longer
Finally, future studies should focus on refining experimental protocols, such as standardizing exercise timing and accounting for individual dietary and lifestyle factors, minimizing confounding variables, and improving the reliability of the findings (Li et al
PlexusDx recommends baseline TSH testing before beginning GLP-1 therapy, then rechecking every 6 to 12 weeks during the first year of treatment